Axsome Therapeutics Overview
Axsome Therapeutics Target Price
Analysts' 12-month price predictions for AXSM.
Get informed when a big investor buys or sells
+ FollowShare Price
$235.26
Average Target Price
$274.06
16.5% upside
16.5% upside18 analysts in the last 4 months
High: $380 | Low: $217
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-07 | RBC CapitalLeonid Timashev | $304 | 29.2% upside |  |
| 2026-06-11 | JefferiesAndrew Tsai | $380 | 61.5% upside | |
| 2026-05-05 | Deutsche BankDavid Hoang | $280 | 19% upside | |
| 2026-05-05 | Morgan Stanley | $242 | 2.9% upside | |
| 2026-05-05 | Needham | $267 | 13.5% upside | |
| 2026-05-05 | Robert W. BairdBrian Skorney | $246 | 4.6% upside | |
| 2026-05-05 | RBC CapitalLeonid Timashev | $302 | 28.4% upside | |
| 2026-05-05 | H.C. Wainwright | $290 | 23.3% upside | |
| 2026-05-04 | Deutsche BankDavid Hoang | $281 | 19.4% upside | |
| 2026-05-04 | JefferiesAndrew Tsai | $275 | 16.9% upside | |
| 2026-05-04 | Oppenheimer | $280 | 19% upside | |
| 2026-05-04 | GuggenheimYatin Suneja | $260 | 10.5% upside | |
| 2026-05-04 | Piper Sandler | $258 | 9.7% upside | |
| 2026-05-04 | Cantor Fitzgerald | $272 | 15.6% upside | |
| 2026-05-04 | H.C. WainwrightRaghuram Selvaraju | $270 | 14.8% upside | |
| 2026-05-01 | Oppenheimer | $250 | 6.3% upside | |
| 2026-04-30 | Morgan Stanley | $217 |  7.8% downside | |
| 2026-04-10 | UBS | $259 | 10.1% upside | |
| 2026-02-24 | RBC Capital | $222 | 5.6% downside | |
| 2026-02-24 | UBS | $251 | 6.7% upside | |
| 2026-02-24 | Morgan Stanley | $207 | 12% downside | |
| 2026-02-24 | Guggenheim | $220 | 6.5% downside | |
| 2026-02-24 | Wells Fargo | $202 | 14.1% downside | |
| 2026-02-23 | Wolfe ResearchRudy Li | $230 | 2.2% downside | |
| 2026-02-23 | Truist FinancialJoon Lee | $200 | 15% downside | |
| 2026-02-23 | Jefferies | $215 | 8.6% downside | |
| 2026-02-19 | Mizuho Securities | $230 | 2.2% downside | |
| 2026-01-21 | RBC CapitalLeonid Timashev | $219 | 6.9% downside | |
| 2026-01-20 | H.C. Wainwright | $260 | 10.5% upside | |
| 2026-01-16 | Piper Sandler | $223 | 5.2% downside | |
| 2026-01-13 | Robert W. Baird | $209 | 11.2% downside | |
| 2026-01-13 | Wells Fargo | $193 | 18% downside | |
| 2026-01-08 | Morgan Stanley | $204 | 13.3% downside | |
| 2026-01-06 | UBS | $248 | 5.4% upside | |
| 2026-01-05 | NeedhamAmi Fadia | $225 | 4.4% downside | |
| 2026-01-05 | H.C. WainwrightRaghuram Selvaraju | $200 | 15% downside | |
| 2026-01-02 | GuggenheimYatin Suneja | $205 | 12.9% downside | |
| 2025-12-31 | Mizuho SecuritiesGraig Suvannavejh | $217 | 7.8% downside | |
| 2025-12-31 | OppenheimerJay Olson | $220 | 6.5% downside | |
| 2025-11-04 | H.C. Wainwright | $185 | 21.4% downside | |
| 2025-11-04 | RBC Capital | $198 | 15.8% downside | |
| 2025-11-04 | Morgan Stanley | $196 | 16.7% downside | |
| 2025-11-04 | Wells Fargo | $157 | 33.3% downside | |
| 2025-10-20 | Morgan StanleySean Laaman | $194 | 17.5% downside | |
| 2025-09-02 | Wells Fargo | $163 | 30.7% downside | |
| 2025-05-06 | Robert W. BairdJoel Beatty | $162 | 31.1% downside | |
| 2025-03-27 | Mizuho SecuritiesGraig Suvannavejh | $216 | 8.2% downside | |
| 2025-03-03 | Robert W. Baird | $160 | 32% downside | |
| 2025-02-03 | Mizuho SecuritiesGraig Suvannavejh | $137 | 41.8% downside | |
| 2025-02-03 | Truist FinancialJoon Lee | $190 | 19.2% downside | |